安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Harrow
Harrow, a growing leader in the North American ophthalmic pharmaceutical market, is dedicated to delivering innovative, accessible, and affordable eyecare solutions
- Harrow Announces First-Quarter 2025 Financial Results
NASHVILLE, Tenn --(BUSINESS WIRE)--May 8, 2025-- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the first quarter ended March 31, 2025 The Company also posted its first quarter Letter to Stockholders and corporate presentation to the “Investors” section of its website, harrow com
- Products - Harrow
Harrow owns an FDA-Registered 503B Outsourcing Facility and a patient-specific 503A pharmacy
- SEC Filings - Harrow, Inc.
Address 1A Burton Hills Blvd , Suite 200 Nashville, TN 37215 Phone (615) 733 4730 (615) 733 4737 (Investor Relations) Social
- Harrow Announces New Appointments to its Board of Directors | Harrow, Inc.
NASHVILLE, Tenn --(BUSINESS WIRE)--Jan 29, 2024-- Harrow (Nasdaq: HROW), a leading U S eyecare pharmaceutical company, today announced the appointments of Adrienne Graves, Ph D , and Lauren Silvernail to the Company’s Board of Directors, effective immediately
- Freshworks - support. harrow. com
You need to enable JavaScript to run this app Freshworks You need to enable JavaScript to run this app
- Executive Management - Harrow, Inc.
John P Saharek is President and Chief Executive Officer of Harrow’s ImprimisRx Division Mr Saharek has over 30 years of broad experience developing and commercializing pharmaceutical, biologic, surgical device and diagnostic product portfolios
- Harrow Announces First-Quarter 2025 Financial Results
NASHVILLE, Tenn --(BUSINESS WIRE)--May 8, 2025-- Harrow (Nasdaq: HROW), a leading North American eyecare pharmaceutical company, announced results for the first quarter ended March 31, 2025 The Company also posted its first quarter Letter to Stockholders and corporate presentation to the Investors section of its website, harrow com
|
|
|